Three Problems.
Three Solutions.
Every pharmaceutical company faces the same structural challenges. We built Krevyos to solve them at the root, not patch the symptoms.
Data Fragmentation
Your Development Scientists and Regulatory teams work on the same product but maintain separate, disconnected records. A change in one system doesn't propagate to others. The result: inconsistencies, rework, and regulatory risk.
Input data once. Krevyos structures it, validates it, and propagates it everywhere—from R&D notebooks to Health Authority applications. Every team sees the same data, always current, always consistent.
Deep dive: Data IntegrityUndetected Change Impact
A formulation change triggers downstream effects across quality specs, stability protocols, and regulatory filings. Today, tracking these dependencies relies on institutional knowledge and manual reviews. One missed link can delay your launch by months.
Our engine maps every relationship between data entities. Change a manufacturing parameter and instantly see which specifications, filings, and stability protocols are affected—before they become rejection letters.
Deep dive: Impact AnalysisAI-Incompatible Data
You can't run AI on a PDF. Decades of pharmaceutical knowledge are trapped in unstructured documents, making predictive analytics and intelligent automation impossible. Your competitors who structure their data first will outpace you.
Krevyos structures your raw data into a format that machine learning models can actually use. Enable predictive stability modeling, intelligent submission optimization, and anomaly detection—without a separate data engineering project.
Deep dive: AI InfrastructureWhich Problem Costs You the Most?
Tell us about your workflows and we'll show you exactly where Krevyos eliminates waste.
Start a Conversation